Blood test predicts risk of infection in RA: study

Measurement of a serum protein important for immune defence could be useful in tailoring treatment for patients with rheumatoid arthritis (RA), West Australian rheumatologists say

Deficiency in the protein, mannose binding lectin (MBL), appears to be a pointer to increased risk of life-threatening infection in vulnerable patients, their research has shown.

Findings from a study of RA patients suggest that measurement of MBL could guide treatment, treatment, particularly for those with other infection risk factors such as being on high-dose prednisolone.